Logotype for Freightways Group Limited

Freightways Group (FRW) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Freightways Group Limited

H1 2025 earnings summary

19 Dec, 2025

Executive summary

  • Revenue grew 6.7% year-over-year to NZD 662.1 million, with EBITDA/EBITA up 6.5% to NZD 86 million and NPAT up 9.5% to NZD 44.7 million, despite challenging New Zealand market conditions.

  • Express Package and Business Mail delivered strong results, with revenue up 5.8–6% and EBITDA/EBITA up 12%, driven by pricing, market share gains, and operational improvements.

  • Information Management and Waste Renewal revenue rose 11.3%, but earnings were flat due to one-off costs and margin contraction.

  • Disciplined capital management and M&A strategy, with investments in automation, infrastructure, and digital capabilities.

  • Interim dividend increased to 19c per share, up from 18c in prior years, totaling about NZD 34 million, payable 1 April 2025.

Financial highlights

  • Group operating revenue rose 6.7% to NZD 662.1 million; EBITA up 6.5% to NZD 86 million; NPAT up 9.5% to NZD 44.7 million.

  • EBITDA/EBITA margin for Express Package division increased by 80 basis points to 14.6%.

  • Same-customer volumes in NZ Express Package declined 3.9% year-over-year, but average pricing per item rose 4.2% to NZD 8.86.

  • Allied Express volumes in Australia grew 8–9%, benefiting from automation and improved economic conditions.

  • Medical waste revenue up 20%, with further growth expected pending a large Victorian tender.

Outlook and guidance

  • Cautiously optimistic for New Zealand activity in H2, expecting slow, incremental organic growth; Australian market remains more buoyant.

  • Focus on restoring margins in FY25 and FY26 as organic growth and market share gains are realized.

  • Full-year CapEx guidance at NZD 35 million, focused on operational tools, IT, and mechanisation.

  • Project Evolve OpEx spend of NZD 5 million in FY25 and FY26, not included in CapEx.

  • Additional Medical Waste revenue delayed to Q4; anticipation of a significant Victorian contract potentially adding NZD 1–4 million annually over five years.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more